← Leaderboards
Laura L Murphy
Southern Illinois University Carbondale
$1,494,242
Attributed
$1,494,242
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $218.3K · FY2005–10$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,494,242 · 4
By mechanism
R21$1,082,944 · 3
R01$411,298 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Female”
- Philip J Disaia · University Of California Irvine$140,003,514
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$103,542,269
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
- Walter John Curran · Thomas Jefferson University$57,608,324
- Gregory S Boebinger · Florida State University$55,673,680
Research focus
FemaleMcf7 CellGene ProteinsDiet Route /ScheduleEatingGene ExpressionCell ProliferationCancer CellCytotoxicityCancer TherapyApoptosisAmericanAdrenalectomyAsiansAnimalsCannabinoidsAdrenocorticotropic HormoneCatalepsyAntioxidantsCannabinoid ReceptorBrain MetabolismBreast Cancer CellCorticotropin Releasing FactorDoxorubicin
Grant awards (9)
Ginseng and its Constituents in Complementary Breast Cancer Therapy$218,250
R21 · FY2010 · AT · contact PI
Ginseng and its Constituents in Complementary Breast Cancer Therapy$181,875
R21 · FY2009 · AT · contact PI
Anti-Cancer Ginsenosides: Their Interactions and Mechanisms of Action$133,294
R21 · FY2007 · CA · contact PI
Anti-Cancer Ginsenosides: Their Interactions and Mechanisms of Action$156,275
R21 · FY2006 · CA · contact PI
Adjuvant Ginseng Use During Breast Cancer Drug Therapy$214,500
R21 · FY2005 · AT
Adjuvant Ginseng Use During Breast Cancer Drug Therapy$178,750
R21 · FY2004 · AT
CANNABINOIDS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS$141,169
R01 · FY2002 · DA
CANNABINOIDS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS$137,059
R01 · FY2001 · DA
CANNABINOIDS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS$133,070
R01 · FY2000 · DA